Expression Vectors Market Size, Share, Segmentation, Trends, and Forecast 2030

Expression Vectors Market

Expression Vectors Market- By Host Type (Bacterial, Insect, Yeast, and Mammalian), By Application (Therapeutic, Research, And Industrial), and By End-User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2022–2028

Published Date: 07-Feb-2023 Category: Technology & Media Report Format : PDF Pages: 150 Report Code: ZMR-579 Status : Published

The global Expression Vectors Market accrued earnings worth approximately 299 (USD Million) in 2021 and is predicted to gain revenue of about 571 (USD Million) by 2028, is set to record a CAGR of nearly 5.4% over the period from 2022 to 2028.

Expression Vectors Market Size

The global Expression Vectors Market Size accrued earnings worth approximately 299 (USD Million) in 2021 and is predicted to gain revenue of about 571 (USD Million) by 2028, is set to record a CAGR of nearly 5.4% over the period from 2022 to 2028. The study provides assessment and analysis of the Expression Vectors Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue

Global Expression Vectors Market Size

Expression Vector Market: Outlook

Expression vector is also termed as expression constructs and is a kind of plasmid derivative that is devised for protein expression in cells. It has features such as replication origin, a selectable marker, and a particular location for gene insertion. Moreover, expression vector possess required elements including transcription termination sequence, strong promotion, and initiation sequence. Breakthroughs in protein expression and launching of new techniques in genetics, molecular biology, and genetic engineering domain will steer growth of expression vector industry.

Global Expression Vectors Market

Expression Vector Market: Growth Aspects

Genetic disorders, occurrence of lifestyle-related ailments, contagious diseases, and huge funding for biologics will steer the expansion of the expression vector industry. Additionally, breakthroughs in protein expression methods and launching of novel techniques in genetics, bioinformatics, and molecular biology domains will spur growth of expression vector market. Apart from this, unmet medical requirements owing to patent expiry of generic medicine will assist industry players in developing new drugs, thereby providing impetus to the expression vector business. However, huge cost of protein treatment and entry barriers as well as high market consolidation can create hindrances in growth path of expression vector market.

Furthermore, large-scale production of human insulin, as well as other protein-based products using expression vectors, will boost expression vectors market trends. Prominent use of expression vectors in research activities related to biomedical and biopharmaceutical products will enlarge scope of expression vectors market growth in upcoming years.

Expression Vector Market Report Scope:

Report Attributes Report Details
Report Name Expression Vectors Market Research Report
Market Size in 2021 USD 299 Million
Market Forecast in 2028 USD 571 Million
Compound Annual Growth Rate CAGR of 5.4%
Number of Pages 150
Forecast Units Value (USD Million), and Volume (Units)
Key Companies Covered Clontech Laboratories, Inc., Merck Millipore, New England Biolabs, Promega Corporation, Sigma-Aldrich Corporation, Bio-Rad Laboratories, Agilent Technologies, QIAGEN, and GenScript USA Inc.
Segments Covered By Host, By End User, By Application, By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Countries Covered North America: U.S and Canada
Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Chile
The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2021
Historical Year 2016 to 2020
Forecast Year 2022 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

 

Expression Vector Market: Regional Landscape

North America To Lead Regional Market Growth In 2022-2028

Growth of expression vector market in North America over forecast timespan is subject to rise in spending of U.S. based firms in biological research. Presence of giant players in Canada and the U.S. will contribute lucratively towards size of expression vectors market in North America.

Expression Vector Market: Competitive Insights

Key players profiled in the study and influencing the market growth are:

  • Clontech Laboratories Inc.
  • Merck Millipore
  • New England Biolabs
  • Promega Corporation
  • Sigma-Aldrich Corporation
  • Bio-Rad Laboratories
  • Agilent Technologies
  • QIAGEN
  • GenScript USA Inc.

The global expression vectors market is segmented as follows:

By Host

  • Bacterial
  • Yeast
  • Insect
  • Mammalian 

By End User 

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • Academic Research Institutes.

By Application 

  • Therapeutic
  • Industrial
  • Research

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

The global Expression Vectors Market is projected to expand over 2022-2028 Expression constructs, also known as expression vectors, are a type of plasmid derivative designed for cellular protein expression. It has characteristics like a specific place for gene insertion, a selectable marker, and a replication origin.

According to study, The global Expression Vectors Market accrued earnings worth approximately 299 (USD Million) in 2021 and is predicted to gain revenue of about 571 (USD Million) by 2028, is set to record a CAGR of nearly 5.4% over the period from 2022 to 2028. 

The global Expression Vectors Market is led by players like Clontech Laboratories, Inc., Merck Millipore, New England Biolabs, Promega Corporation, Sigma-Aldrich Corporation, Bio-Rad Laboratories, Agilent Technologies, QIAGEN, and GenScript USA Inc.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed